Journal article

Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR

RB Luwor, TG Johns, C Murone, HJS Huang, WK Cavenee, G Ritter, LJ Old, AW Burgess, AM Scott

Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2001

University of Melbourne Researchers

Andrew Scott Author Medicine - Austin Health

Antony Burgess Author Surgery - Royal Melbourne Hospital

Rodney Luwor Author Surgery - Royal Melbourne Hospital

Citation metrics

136Web of Science

Keywords

Life Sciences & Biomedicine

Lung Carcinomas

Malignant Gliomas

Tumor Cells, Cultured

Protein Binding

Xenograft Model Antitumor Assays

Immunohistochemistry

Confers Enhanced Tumorigenicity

Transplantation, Heterologous

Neoplasms, Experimental

Receptor, Epidermal Growth Factor

Precipitin Tests

Treatment Outcome

Antineoplastic Agents

Gene Expression Regulation, Neoplastic

Antibodies, Monoclonal

Science & Technology